Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

v3.21.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2020
Income Tax Disclosure [Abstract]  
Schedule of deferred tax assets
    As of December 31,  
    2020     2019  
Current:            
Accrued expenses   $ 464,042     $ 223,712  
                 
Stock compensation     869,815       838,753  
                 
Net operating loss carryforward     16,165,927       11,978,595  
                 
Research and development credit carry forward     548,983       367,261  
                 
  Total deferred tax assets     18,048,767       13,408,321  
                 
Valuation allowance     (18,048,767 )     (13,408,321 )
                 
Deferred tax asset, net of valuation allowance   $ -     $ -  
Schedule of statutory federal income tax rate
    For the Years Ended
December 31,
 
    2020     2019  
U.S. statutory federal rate     (21.0 )%     (21.0 )%
State income taxes, net of federal tax     (7.0 )%     (7.0 )%
Federal tax rate change     - %     - %
Permanent differences     0.4 %     3.0 %
Prior year true-ups     (0.4 )%     0.3 %
R&D tax credit     (0.5 )%     (0.7 )%
Change in valuation allowance     28.5 %     25.4 %
Income tax provision (benefit)     - %     - %
Schedule of income tax provision
    For the Years Ended
December 31,
 
    2020     2019  
Federal            
Current   $ -     $ -  
Deferred     (3,482,375 )     (2,378,218 )
State and local                
Current     -       -  
Deferred     (1,158,072 )     (790,882 )
Change in valuation allowance     4,640,447       3,169,100  
Income tax provision (benefit)   $ -     $ -